Dishman Carbogen Amcis Limited — Updates, 10-01-2025: Press Release

CARBOGEN AMCIS AG, a wholly-owned subsidiary of Dishman Carbogen Amcis Limited, has successfully completed the Swissmedic inspection of its Vionnaz facility in Switzerland. This two-day inspection confirmed the site's compliance with stringent regulatory standards, renewing its GMP Certification. The inspection, which took place in November 2024, primarily assessed the Quality Management System, focusing on the development and manufacturing of highly potent Active Pharmaceutical Ingredients (APIs).

Quality Director Hélène Mazuel emphasized the team’s dedication to maintaining high-quality standards, highlighting that this inspection continues a successful track record since 2015. The Vionnaz facility is equipped for the development and small-scale production of highly potent APIs, including advanced capabilities for antibody-drug conjugates. This achievement reinforces CARBOGEN AMCIS’s strong reputation for compliance, contributing to a positive outlook as it continues delivering critical services in the pharmaceutical industry. Shareholders should monitor this development closely as it could enhance the company's competitive positioning and operational efficiency.